The demand for weight loss drugs like Ozempic and Wegovy has led to a flood of fake drugs hitting the market. However, these ...

Ozempic continues to grow in popularity in weight loss use. However, low-income patient populations who have an increased ...

The Corner Booth The Quebec Liberals want semaglutide — also known as Ozempic — to be covered by medicare for weight loss.

With the government—meaning taxpayers and out-of-control borrowing—picking up the tab, third-party coverage is likely to drive much greater demand for Medicare-subsidized Ozempic and home ...

It's no surprise that campaigning for office is largely a matter of buying votes with unrealistic promises of largesse to be funded—if the promise is ever fulfilled—on the backs of those to be ...

The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...

Novo Nordisk reported mixed Q3 earnings, but GLP-1 drugs contributed to revenue strength. The company also adjusted its ...

This list can have an impact on your drug coverage in 2025 and shows why this open enrollment is so important.

Third quarter sales of Novo’s in-demand obesity drug totaled $2.5 billion, roughly 81% higher than the same period in 2023 and nearly doubling the total for Lilly’s Zepbound.

Across the country candidates are talking about issues like border control and abortion. Schweikert prefers discussing the ...